Biodexa Pharmaceuticals (BDRX) Preferred Stock Liabilities (2014 - 2015)

Biodexa Pharmaceuticals has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $303498.1 for Q4 2015.

• In Q4 2015, Preferred Stock Liabilities fell 76.06% year-over-year to $303498.1; the TTM figure through Dec 2015 stood at $303498.1 (down 76.06% YoY), while the FY2015 annual figure was $303498.1, down 76.98% from the prior year.
• Preferred Stock Liabilities came in at $303498.1 for Q4 2015 at Biodexa Pharmaceuticals, down from $1.3 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $1.3 million in Q4 2014 to a low of $303498.1 in Q4 2015.